Chester County News and Community Website
CHESTERBROOK, PA — Trevena, Inc. (Nasdaq: TRVN) announced a recent publication in Expert Review of Neurotherapeutics titled “A critical review of oliceridine injection as an IV opioid analgesic for the …
Trevena Announces the Publication of an Expert Review on the Clinical Profile of OLINVYK Read More
WASHINGTON, D.C. — The U.S. Food and Drug Administration recently took new steps aimed at fostering the development of non-addictive alternatives to opioids to manage acute pain and decreasing exposure …
FDA Takes Steps Aimed at Fostering Development of Non-Addictive Alternatives to Opioids for Acute Pain Management Read More
WASHINGTON, D.C. — The U.S. Food and Drug Administration this week authorized marketing of EaseVRx, a prescription-use immersive virtual reality (VR) system that uses cognitive behavioral therapy and other behavioral …
FDA Authorizes Marketing of Virtual Reality System for Chronic Pain Reduction Read More CHESTERBROOK, PA —Trevena, Inc. (Nasdaq: TRVN) this week announced the publication of an exploratory analysis evaluating the safety of OLINVYK (oliceridine) injection and IV morphine, using data from the OLINVYK Phase …
Trevena Announces Publication Highlighting Risk / Benefit Analysis of OLINVYK in Pain and Therapy Read More
WASHINGTON, D.C. — The Federal Trade Commission is sending refund checks totaling more than $350,000 to consumers who bought Willow Curve, a device that applies low-level light and, according to …
Refunds Coming to Consumers Who Bought Deceptively Marketed Willow Curve Device Read More
MEMPHIS, TN — On Thursday, June 17, U.S. Customs and Border Protection Officers in Memphis, Tennessee examined a package described in the paperwork by the shipper as “AS PER INVOICE …
Customs and Border Protection Officers Seize 4.2 Kilos of “Personal Use” Clovidol Opioids Read More
MALVERN, PA — Baudax Bio, Inc. (NASDAQ: BXRX), a pharmaceutical company focused on therapeutics for acute care settings, announced that the results of the Phase IIIb study evaluating ANJESO (meloxicam) …
Baudax Bio Announces Publication of Phase IIIb ANJESO® Data Read More